Collagen VI myopathies: from the animal model to the clinical trial.
Maraldi
Nadir M
NM
Laboratory of Cell Biology, Institute "Rizzoli", Bologna, Italy. maraldi@area.bo.cnr.it
Sabatelli
Patrizia
P
Columbaro
Marta
M
Zamparelli
Alessandra
A
Manzoli
Francesco A
FA
Bernardi
Paolo
P
Bonaldo
Paolo
P
Merlini
Luciano
L
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002986:Clinical Trials as Topic; D024142:Collagen Type VI / Q000235:genetics / Q000378:metabolism* / Q000648:ultrastructure; D016572:Cyclosporine / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005109:Extracellular Matrix / Q000378:metabolism / Q000648:ultrastructure; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology / Q000648:ultrastructure; D009135:Muscular Diseases / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D009154:Mutation
D024142:Collagen Type VI; D004791:Enzyme Inhibitors; D016572:Cyclosporine